Education
About Us
Working with TipRanks
Follow Us
RaySearch Laboratories AB Class B (RSLBF)
OTHER OTC:RSLBF
RESEARCH TOOLSreports
Earnings Data
Report Date
Aug 08, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.13Last Year’s EPS
0.19Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 09, 2025
|% Change Since: 33.09%
|Next Earnings Date:Aug 08, 2025
Earnings Call Sentiment|Positive
RaySearch had a strong Q3 2024 with record-breaking sales and improved operating profit and margin. Key strategic milestones were achieved, such as RayCare's integration with Varian TrueBeam. Despite these successes, there were some challenges, including a decrease in support order intake and lower cash flow from operations. However, the overall sentiment of the call indicates a positive outlook for future growth, supported by increased financial targets.Company Guidance
In the third quarter of 2024, RaySearch reported their highest-ever sales of SEK 293 million, a 19% increase from the same period in 2023, with an operating profit of SEK 62 million and an operating margin of 21%. License revenue rose to SEK 133 million, and order intake reached SEK 253 million. The company maintained a strong financial position, with cash and cash equivalents totaling SEK 425 million and no loans. Notably, cash flow from operations was SEK 61 million. Additionally, the company anticipates RayCare will significantly contribute to revenue in 2025 and 2026, marking a promising growth trajectory. RaySearch also achieved a rolling 12-month net sales of SEK 1.169 billion by the end of September 2024, with a backlog expected to generate SEK 471 million in net sales in the following 12 months. Looking forward, the Board increased the operating margin target to at least 25% by 2026, reflecting confidence in sustained growth and profitability.Record Sales and Revenue Growth
Q3 2024 sales reached an all-time high of SEK 293 million, a 19% increase compared to Q3 2023. The net sales for the first 9 months of 2024 increased by 20% to SEK 869 million from SEK 723 million in 2023.
Strong Operating Profit and Margin
Operating profit for Q3 2024 was SEK 62 million with a margin of 21%, compared to SEK 29 million and an 11.3% margin in Q3 2023. The operating profit for the first 9 months of 2024 was SEK 187 million, up from SEK 71 million in 2023, with an improved margin of 21.5%.
Milestone with RayCare and Varian TrueBeam
Iridium Network in Belgium treated their first patient using RayCare with a Varian TrueBeam linear accelerator, increasing RayCare's market potential significantly.
Increased Financial Targets
The operating margin target for 2026 has been raised from 20% to 25% due to consistent strong performance.
RSLBF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
RSLBF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 09, 2025 | $24.42 | $31.86 | +30.47% |
Feb 21, 2025 | $24.90 | $24.90 | 0.00% |
Nov 08, 2024 | $15.00 | $17.29 | +15.27% |
Aug 16, 2024 | $12.82 | $14.44 | +12.64% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does RaySearch Laboratories AB Class B (RSLBF) report earnings?
RaySearch Laboratories AB Class B (RSLBF) is schdueled to report earning on Aug 08, 2025, TBA Not Confirmed.
What is RaySearch Laboratories AB Class B (RSLBF) earnings time?
RaySearch Laboratories AB Class B (RSLBF) earnings time is at Aug 08, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is RSLBF EPS forecast?
RSLBF EPS forecast for the fiscal quarter 2025 (Q2) is 0.13.